{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:00:48Z","timestamp":1762459248729},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T00:00:00Z","timestamp":1427500800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-0650-0","type":"journal-article","created":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T20:40:38Z","timestamp":1427488838000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Katherine L","family":"Fielding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salome","family":"Charalambous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mpho","family":"Tlali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E","family":"Dorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Vassall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin J","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison D","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,28]]},"reference":[{"issue":"12","key":"650_CR1","doi-asserted-by":"publisher","first-page":"e28691","DOI":"10.1371\/journal.pone.0028691","volume":"6","author":"A Gupta","year":"2011","unstructured":"Gupta A, Nadkarni G, Yang WT, Chandrasekhar A, Gupte N, Bisson GP, et al. Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS One. 2011;6(12):e28691.","journal-title":"PLoS One"},{"issue":"4","key":"650_CR2","first-page":"183","volume":"12","author":"JA Cox","year":"2010","unstructured":"Cox JA, Lukande RL, Lucas S, Nelson AM, Van Marck E, Colebunders R. Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses. AIDS Rev. 2010;12(4):183\u201394.","journal-title":"AIDS Rev"},{"issue":"10","key":"650_CR3","doi-asserted-by":"publisher","first-page":"e47542","DOI":"10.1371\/journal.pone.0047542","volume":"7","author":"EB Wong","year":"2012","unstructured":"Wong EB, Omar T, Setlhako GJ, Osih R, Feldman C, Murdoch DM, et al. Causes of death on antiretroviral therapy: a post-mortem study from South Africa. PLoS One. 2012;7(10):e47542.","journal-title":"PLoS One"},{"key":"650_CR4","unstructured":"Karat SC, Tlali M, Fielding K, Hoffman C, Johnson S, Churchyard G, et al. Investigation for tuberculosis delays start of antiretroviral therapy in South African primary care clinics. Int J Tuberc Lung Dis. 2013; 17(12) supplement 2:S431"},{"issue":"5","key":"650_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.7196\/SAMJ.8290","volume":"104","author":"GJ Churchyard","year":"2014","unstructured":"Churchyard GJ, Chaisson RE, Maartens G, Getahun H. Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB control. S Afr Med J. 2014;104(5):339\u201343.","journal-title":"S Afr Med J"},{"key":"650_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/1573398X113099990015","volume":"9","author":"MP Nicol","year":"2013","unstructured":"Nicol MP, Whitelaw A, Wendy S. Using Xpert MTB\/RIF. Curr Respir Med Rev. 2013;9:187\u201392.","journal-title":"Curr Respir Med Rev"},{"key":"650_CR7","series-title":"Policy update","volume-title":"Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children, Policy update. Geneva: WHO; 2013. Available from: \n                    http:\/\/www.stoptb.org\/wg\/gli\/assets\/documents\/WHO%20Policy%20Statement%20on%20Xpert%20MTB-RIF%202013%20pre%20publication%2022102013.pdf\n                    \n                  . (Accessed 23March2015)."},{"issue":"11","key":"650_CR8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","volume":"363","author":"CC Boehme","year":"2010","unstructured":"Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363(11):1005\u201315.","journal-title":"N Engl J Med"},{"key":"650_CR9","doi-asserted-by":"crossref","unstructured":"Churchyard GJ, Stevens WS, Mametja LD, McCarthy KM, Chihota V, Nicol MP, et al. Xpert MTB\/RIF replacing sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out. Lancet Global Health. 2015. in press.","DOI":"10.1016\/S2214-109X(15)00100-X"},{"issue":"9915","key":"650_CR10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0140-6736(13)62073-5","volume":"383","author":"G Theron","year":"2014","unstructured":"Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, Lesosky M, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB\/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet. 2014;383(9915):424\u201335.","journal-title":"Lancet"},{"key":"650_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2334-12-103","volume":"12","author":"SD Lawn","year":"2012","unstructured":"Lawn SD. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis. 2012;12:103.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"650_CR12","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.5588\/ijtld.11.0733","volume":"16","author":"Y Hanifa","year":"2012","unstructured":"Hanifa Y, Fielding KL, Charalambous S, Variava E, Luke B, Churchyard GJ, et al. Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding. Int J Tuberc Lung Dis. 2012;16(9):1252\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"650_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/QAI.0000000000000091","volume":"66","author":"AD Kerkhoff","year":"2014","unstructured":"Kerkhoff AD, Wood R, Vogt M, Lawn SD. Predictive value of anemia for tuberculosis in HIV-infected patients in Sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays. J Acquir Immune Defic Syndr. 2014;66(1):33\u201340.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"650_CR14","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1097\/QAI.0b013e318251ae0b","volume":"60","author":"T Kufa","year":"2012","unstructured":"Kufa T, Mngomezulu V, Charalambous S, Hanifa Y, Fielding K, Grant AD, et al. Undiagnosed tuberculosis among HIV clinic attendees: association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection control. J Acquir Immune Defic Syndr. 2012;60(2):e22\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"650_CR15","doi-asserted-by":"publisher","first-page":"e1001067","DOI":"10.1371\/journal.pmed.1001067","volume":"8","author":"SD Lawn","year":"2011","unstructured":"Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB\/RIF assay: a prospective study. PLoS Med. 2011;8(7):e1001067.","journal-title":"PLoS Med"},{"issue":"6","key":"650_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","volume":"21","author":"D Moore","year":"2007","unstructured":"Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, et al. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS. 2007;21(6):713\u20139.","journal-title":"AIDS"},{"key":"650_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/1471-2458-10-433","volume":"10","author":"EC Russell","year":"2010","unstructured":"Russell EC, Charalambous S, Pemba L, Churchyard GJ, Grant AD, Fielding K. Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study. BMC Public Health. 2010;10:433.","journal-title":"BMC Public Health"},{"issue":"2","key":"650_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/QAI.0b013e3181b98430","volume":"52","author":"M Shah","year":"2009","unstructured":"Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, et al. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a high HIV prevalence setting. J Acquir Immune Defic Syndr. 2009;52(2):145\u201351.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"650_CR19","doi-asserted-by":"publisher","DOI":"10.1201\/9781584888178","volume-title":"Cluster randomised trials","author":"RJ Hayes","year":"2009","unstructured":"Hayes RJ, Moulton LH. Cluster randomised trials. Boca Raton, FL: Chapman & Hall\/CRC Press; 2009."},{"issue":"1","key":"650_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/tmi.12230","volume":"19","author":"V Simms","year":"2014","unstructured":"Simms V, Matiku S, Ngowi B, Chanda D, Lesikari S, Bottomley C, et al. Integrating public health research trials into health systems in Africa: individual or cluster randomisation? Tropical Med Int Health. 2014;19(1):123\u20137.","journal-title":"Tropical Med Int Health"},{"issue":"3","key":"650_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/QAI.0b013e31823219d1","volume":"58","author":"CJ Hoffmann","year":"2011","unstructured":"Hoffmann CJ, Fielding KL, Johnston V, Charalambous S, Innes C, Moore RD, et al. Changing predictors of mortality over time from cART start: implications for care. J Acquir Immune Defic Syndr. 2011;58(3):269\u201376.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"650_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/QAI.0b013e3182893fb4","volume":"63","author":"CJ Hoffmann","year":"2013","unstructured":"Hoffmann CJ, Lewis JJ, Dowdy DW, Fielding KL, Grant AD, Martinson NA, et al. Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model. J Acquir Immune Defic Syndr. 2013;63(1):105\u201311.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"650_CR23","unstructured":"Grant AD. TB Fast Track trial. Available from: \n                    http:\/\/www.isrctn.com\/ISRCTN35344604\n                    \n                  . Accessed 23 March 2015."},{"key":"650_CR24","unstructured":"Cobelens F, Manabe Y. Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment (PrOMPT). Available from: \n                    http:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT01417988\n                    \n                  . Accessed 23 March 2015."},{"key":"650_CR25","unstructured":"Hosseinipour MC, Kumwenda J. REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment. Available from: \n                    http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01380080\n                    \n                  . Accessed 23 March."},{"key":"650_CR26","unstructured":"Blanc FX, Domoua KMS. Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART with CD4 Cell Counts <100\/mm3 (STATIS trial). Available from: \n                    http:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02057796\n                    \n                  . Accessed 23 March 2015."},{"key":"650_CR27","unstructured":"Egwaga S. Home care and routine: cryptococcal meningitis screening among patients starting antiretroviral therapy with advanced disease (REMSTART trial). Available from: \n                    http:\/\/www.isrctn.com\/ISRCTN20410413\n                    \n                  . Accessed 23 March 2015."},{"key":"650_CR28","unstructured":"Gibb D. Reduction of Early mortALITY in HIV-infected African adults and children starting antiretroviral therapy: REALITY trial. Available from: \n                    http:\/\/www.isrctn.com\/ISRCTN43622374\n                    \n                  . Accessed 23 March 2015."},{"issue":"5","key":"650_CR29","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jclinepi.2008.12.011","volume":"62","author":"KE Thorpe","year":"2009","unstructured":"Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009;62(5):464\u201375.","journal-title":"J Clin Epidemiol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0650-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-0650-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0650-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0650-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:51:51Z","timestamp":1553640711000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-0650-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,28]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-0650-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,28]]},"assertion":[{"value":"21 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"125"}}